<SEC-DOCUMENT>0001125345-20-000155.txt : 20201130
<SEC-HEADER>0001125345-20-000155.hdr.sgml : 20201130
<ACCEPTANCE-DATETIME>20201130163319
ACCESSION NUMBER:		0001125345-20-000155
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20201125
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201130
DATE AS OF CHANGE:		20201130

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MACROGENICS INC
		CENTRAL INDEX KEY:			0001125345
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36112
		FILM NUMBER:		201358472

	BUSINESS ADDRESS:	
		STREET 1:		9704 MEDICAL CENTER DRIVE
		CITY:			Rockville
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		301-251-5172

	MAIL ADDRESS:	
		STREET 1:		9704 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mgnx-20201125.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:bef8762b-7935-441c-abc4-a2dc43a0414d,g:fd84582f-305c-4baa-8794-528d195fb06f,d:fb6d2ee08b5c4984b0baa85b1941c64d--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mgnx-20201125</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF80L2ZyYWc6MzE1NWM5OTJlNGVlNDcxMzkzZjNiNzRhNTc1OGUyZmYvdGFibGU6M2QxMGFmM2M3OGYxNDVjM2FjOGExMGUxNzU0YWEyYTUvdGFibGVyYW5nZTozZDEwYWYzYzc4ZjE0NWMzYWM4YTEwZTE3NTRhYTJhNV8yLTEtMS0xLTA_a2ada3e1-9c57-458f-8b9f-b892e2ec330d">0001125345</ix:nonNumeric><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF80L2ZyYWc6MzE1NWM5OTJlNGVlNDcxMzkzZjNiNzRhNTc1OGUyZmYvdGFibGU6M2QxMGFmM2M3OGYxNDVjM2FjOGExMGUxNzU0YWEyYTUvdGFibGVyYW5nZTozZDEwYWYzYzc4ZjE0NWMzYWM4YTEwZTE3NTRhYTJhNV8zLTEtMS0xLTA_ca6113b8-9952-40ab-b16f-1f457dde932a">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mgnx-20201125.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125345</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-16</xbrli:startDate><xbrli:endDate>2020-06-16</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ifb6d2ee08b5c4984b0baa85b1941c64d_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ2_044aaee5-a154-48d9-9cd7-1da13d9681c3">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported):&#160; <ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8yMzI_ffd96351-51ff-4a68-ab34-00fe7185c27e">November 25, 2020</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQy_d4bf748d-291a-436e-b6e8-c2d4fa3fc348">MACROGENICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (Exact Name of Registrant as Specified in Charter)</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.948%"><tr><td style="width:1.0%"></td><td style="width:18.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl8wLTAtMS0xLTA_e171eaa0-02e1-49c0-8992-8922044e0945">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl8wLTMtMS0xLTA_3e536cb7-24eb-45f9-89ac-12f4ff82668c">001-36112</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl8wLTUtMS0xLTA_a442fb1e-2ed7-45e0-99e2-c79d8528566a">06-1591613</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;Identification No.)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl8zLTAtMS0xLTA_a0d8dfa7-38c3-4248-a5d3-bdada6f431dc">9704 Medical Center Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl80LTAtMS0xLTA_48f5f846-300c-4b94-ab35-d51e6bdaf751">Rockville,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl80LTEtMS0xLTA_d40ab896-528d-460d-bc1c-7e3bf22a0b94">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl80LTMtMS0xLTA_e7dcfa55-8a79-4a8e-b7da-fbb95ce16034">20850</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code:&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQz_68be31d0-5950-482c-abac-53c65b1981b1">301</ix:nonNumeric>) <ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ3_48ba5f3c-e2d6-49ac-a7f9-9a04b9af6896">251-5172</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not applicable&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;padding-right:15.75pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6OTBmMTQyZTI3MWM2NGI1M2E4NzgyZWM3NjlkNGIwNTAvdGFibGVyYW5nZTo5MGYxNDJlMjcxYzY0YjUzYTg3ODJlYzc2OWQ0YjA1MF8xLTAtMS0xLTA_05e41695-b926-4427-b34c-be93450eb6c8">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6OTBmMTQyZTI3MWM2NGI1M2E4NzgyZWM3NjlkNGIwNTAvdGFibGVyYW5nZTo5MGYxNDJlMjcxYzY0YjUzYTg3ODJlYzc2OWQ0YjA1MF8xLTEtMS0xLTA_b0e94a0c-dfd6-4084-84f7-ea5b50efbeb3">MGNX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6OTBmMTQyZTI3MWM2NGI1M2E4NzgyZWM3NjlkNGIwNTAvdGFibGVyYW5nZTo5MGYxNDJlMjcxYzY0YjUzYTg3ODJlYzc2OWQ0YjA1MF8xLTItMS0xLTA_0399aa45-fc83-4fdc-b8ce-f548180e668f">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5.25pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ4_85d2aad1-c697-4d02-8f4f-7e83af7bd052">&#9744;</ix:nonNumeric> Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ0_331c161f-c6d1-4379-8a8e-930f2e0592b2">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ5_e24fbad5-f61f-47b9-ac0e-80f8bbcb5b28">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ1_1e069bea-a441-4f1c-b57b-7daa8c1dcd08">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  <ix:nonNumeric contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjUw_5e13164d-5bfd-4b79-9dcc-ae583a5550d6">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   &#9744;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ifb6d2ee08b5c4984b0baa85b1941c64d_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entry into a Material Definitive Agreement</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;25, 2020,  </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MacroGenics entered into a Product Commercialization A</span><span style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">greement, or the Agreement,</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with </span><span style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EVERSANA Life Sciences Services, LLC, or Eversana, for the potential commercialization of MacroGenics&#8217; investigational product, margetuximab. Pursuant to the </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement, Eversana will provide commercialization services to MacroGenics, as well as </span><span style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the provision of marketing, sales, logistics and other services, </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if margetuximab is approved by the United States Food &amp; Drug Administration (FDA)</span><span style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Agreement, MacroGenics will maintain ownership of, and will have legal, regulatory, and manufacturing responsibilities for, margetuximab.</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eversana will utilize its internal capabilities to support sales and marketing, market access, channel management services, data and analytics, medical affairs, and other patient access related services. MacroGenics will book sales for margetuximab.</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Agreement, Eversana will conduct the commercialization activities according to an agreed upon plan and budget.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to a potential FDA approval of margetuximab, MacroGenics will pay Eversana on a fee-for-service basis for its services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter, the parties will share costs equally and Eversana will earn future revenue share payments which shall be capped at 125% of Eversana&#8217;s cumulative service fees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the cap is reached, MacroGenics will compensate Eversana for its services on a fee-for-service basis.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term of the Agreement is from the date of execution until five years from the date, if any, of an FDA approval of margetuximab.</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Agreement may be earlier terminated (i) by Eversana for pre-defined product performance reasons, or (ii) by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MacroGenics for convenience by providing notice no earlier than 24 months post FDA approval of margetuximab, or for a change of product control, including an exclusive licensing arrangement for margetuximab with a third-party.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the complete Product Commercialization Agreement, which will be filed in redacted form as an exhibit to the Company&#8217;s Annual Report on Form 10-K for the year ending December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2020, MacroGenics issued a press release announcing that MacroGenics entered into the Agreement with Eversana.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. </span></div><div><span><br/></span></div><div id="ifb6d2ee08b5c4984b0baa85b1941c64d_47"></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:16.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Item 9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Financial Statements and Exhibits</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(d) Exhibits.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Description of Exhibit</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="eversanapressrelease.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="eversanapressrelease.htm">Press Release dated </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="eversanapressrelease.htm">November </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="eversanapressrelease.htm">30, 2020</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div id="ifb6d2ee08b5c4984b0baa85b1941c64d_10"></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.032%"><tr><td style="width:1.0%"></td><td style="width:44.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MACROGENICS, INC.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:  November 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President and General Counsel</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>eversanapressrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="if8260c1fe93945aabe3efaecb78a5678_32"></div><div style="min-height:108pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="text-align:justify"><img alt="image2.jpg" src="image2.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:123px"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><img alt="image1.jpg" src="image1.jpg" style="height:60px;margin-bottom:5pt;vertical-align:text-bottom;width:134px"></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13pt;font-weight:700;line-height:115%">MacroGenics and EVERSANA Announce Agreement to Support the Potential Launch and Commercialization of Margetuximab</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:14.15pt">MacroGenics accesses EVERSANA&#8217;s full suite of commercial services for which both parties share expenses</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:14.15pt">EVERSANA may earn revenue share payments over five years subject to predefined cap</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:14.15pt">MacroGenics&#8217; projected cash runway remains into 2023</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ROCKVILLE, MD and CHICAGO, IL, November 30, 2020 (GLOBE NEWSWIRE)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> -- MacroGenics, Inc. (Nasdaq&#58; MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that it has partnered with EVERSANA, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a pioneer of next-generation commercial services to the global life sciences industry</font><font style="color:#222222;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to commercialize margetuximab in the United States, if approved. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Margetuximab is an investigational, monoclonal antibody derived from MacroGenics&#8217; proprietary Fc-Optimization technology platform. A Biologics License Application (BLA) for margetuximab for the treatment of patients with pre-treated metastatic HER2-positive breast cancer in combination with chemotherapy is under review by the U.S. Food and Drug Administration (FDA), with a Prescription Drug User Fee Act (PDUFA) goal date of December 18, 2020. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;We believe that margetuximab, if approved, could become a valuable treatment option for patients living with this devastating disease,&#8221; said Scott Koenig, M.D., Ph.D., President and CEO of MacroGenics. &#8220;We are excited to partner with EVERSANA and leverage their integrated commercial services to efficiently launch margetuximab. We have been working closely with EVERSANA to fully align our commercialization strategies to educate healthcare providers and ensure patient access to margetuximab, while maintaining MacroGenics&#8217; cash runway to fund our broader portfolio.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Jim Lang, CEO of EVERSANA, added, &#8220;We&#8217;ve built a suite of comprehensive commercial services for biopharmaceutical innovators like MacroGenics and look forward to entering this risk-sharing arrangement with MacroGenics to support the commercialization of margetuximab, if approved. Our partnership with MacroGenics puts the patient first by supporting broad market access and comprehensive patient support services. We will work closely with MacroGenics on each stage of the product launch and roll-out.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Under the terms of the agreement, MacroGenics maintains ownership of margetuximab, including all manufacturing, regulatory and development responsibilities for the product. This includes MacroGenics&#8217; continued development of margetuximab in combination with immune checkpoint inhibitors in gastroesophageal cancer in the Phase 2&#47;3 MAHOGANY study, as well as other ongoing studies. EVERSANA receives a co-exclusive right to conduct approved commercialization activities. EVERSANA will utilize its internal capabilities to support sales and marketing, market access, </font><font style="color:#333333;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">channel </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font><br></font></div></div><div><font style="color:#333333;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">management services, data and analytics, medical affairs, and other patient access related services.  MacroGenics will book sales for margetuximab.  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon the potential approval of margetuximab, EVERSANA and MacroGenics will equally share in funding EVERSANA&#8217;s commercialization expenses. In exchange for co-funding these expenses, EVERSANA will earn future revenue share payments which shall be capped at 125% of EVERSANA&#8217;s cumulative service fees. The term of the agreement is five years following the date of FDA approval, subject to predefined termination provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About HER2-Positive Breast Cancer </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Human epidermal growth factor receptor 2 (HER2) is a protein found on the surface of some cancer cells that promotes growth and is associated with aggressive disease and poor prognosis. Approximately 15-20% of breast cancer cases are HER2-positive. Antibody-based therapies targeting HER2 have greatly improved outcomes of patients with HER2-positive breast cancer and are now standard of care in both early-and late-stage disease. However, metastatic breast cancer remains an area of unmet need and ongoing HER2 blockade is recommended for the treatment of patients with relapsed or refractory disease.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Margetuximab</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Margetuximab is an Fc-engineered, monoclonal antibody that targets the HER2 oncoprotein. HER2 is expressed by tumor cells in breast, gastroesophageal and other solid tumors. Margetuximab was designed to provide HER2 blockade and has similar HER2 binding and antiproliferative effects as trastuzumab. In addition, margetuximab has been engineered to enhance the engagement of the immune system through MacroGenics&#8217; Fc Optimization technology. Margetuximab is also being evaluated in combination with checkpoint blockade in the Phase 2&#47;3 MAHOGANY trial for the treatment of patients with HER2-positive gastroesophageal cancer (NCT04082364), and in combination with tebotelimab (PD-1 &#215; LAG-3 bispecific DART&#174; molecule) in various HER2+ indications (NCT03219268). For more information, please visit </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">www.clinicaltrials.gov</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About MacroGenics, Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. For more information, please see the Company's website at www.macrogenics.com. MacroGenics, the MacroGenics logo and DART are trademarks or registered trademarks of MacroGenics, Inc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About EVERSANA&#8482;</font></div><div><font style="background-color:#ffffff;color:#222222;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">EVERSANA&#8482; is the leading provider of global services to the life sciences industry. The company&#8217;s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life science solutions for a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div><font><br></font></div></div><div><font style="background-color:#ffffff;color:#222222;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">healthier world. To learn more about EVERSANA, visit </font><font style="background-color:#ffffff;color:#007398;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">eversana.com</font><font style="background-color:#ffffff;color:#222222;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or connect through </font><font style="background-color:#ffffff;color:#007398;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">LinkedIn</font><font style="background-color:#ffffff;color:#222222;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="background-color:#ffffff;color:#007398;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Twitter</font><font style="background-color:#ffffff;color:#222222;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MacroGenics&#8217; Cautionary Note on Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any statements in this press release about future expectations, plans and prospects for MacroGenics, Inc. (the &#8220;Company&#8221;), including statements about the Company's strategy, future operations, clinical development of the Company's therapeutic candidates, milestone or opt-in payments from the Company's collaborators, the Company's anticipated milestones and future expectations and plans and prospects for the Company and other statements containing the words &#34;subject to&#34;, &#34;believe&#34;, &#34;anticipate&#34;, &#34;plan&#34;, &#34;expect&#34;, &#34;intend&#34;, &#34;estimate&#34;, &#34;project&#34;, &#34;may&#34;, &#34;will&#34;, &#34;should&#34;, &#34;would&#34;, &#34;could&#34;, &#34;can&#34;, the negatives thereof, variations thereon and similar expressions, or by discussions of strategy constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including&#58; the uncertainties inherent in the initiation and enrollment of future clinical trials, expectations of expanding ongoing clinical trials, availability and timing of data from ongoing clinical trials, expectations for the timing and steps required in the regulatory review process, expectations for regulatory approvals, the impact of competitive products, our ability to enter into agreements with strategic partners and other matters that could affect the availability or commercial potential of the Company's product candidates, business or economic disruptions due to catastrophes or other events, including natural disasters or public health crises such as the novel coronavirus (referred to as COVID-19), and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company's views only as of the date hereof. The Company anticipates that subsequent events and developments will cause the Company's views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so, except as may be required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Contacts&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">MacroGenics, Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Jim Karrels, Senior Vice President, CFO</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:115%">info&#64;macrogenics.com</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">1-301-251-5172</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:115%">EVERSANA</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Sarah Zwicky</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:115%">sarah.zwicky&#64;eversana.com</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">1-414-434-4691</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mgnx-20201125.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:bef8762b-7935-441c-abc4-a2dc43a0414d,g:fd84582f-305c-4baa-8794-528d195fb06f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mgnx="http://macrogenics.com/20201125" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://macrogenics.com/20201125">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgnx-20201125_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgnx-20201125_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgnx-20201125_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mgnx-20201125_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://macrogenics.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>mgnx-20201125_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:bef8762b-7935-441c-abc4-a2dc43a0414d,g:fd84582f-305c-4baa-8794-528d195fb06f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://macrogenics.com/role/Cover" xlink:type="simple" xlink:href="mgnx-20201125.xsd#Cover"/>
  <link:calculationLink xlink:role="http://macrogenics.com/role/Cover" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>mgnx-20201125_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:bef8762b-7935-441c-abc4-a2dc43a0414d,g:fd84582f-305c-4baa-8794-528d195fb06f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://macrogenics.com/role/Cover" xlink:type="simple" xlink:href="mgnx-20201125.xsd#Cover"/>
  <link:definitionLink xlink:role="http://macrogenics.com/role/Cover" xlink:type="extended" id="i481aa17119fe467b8246f69f7c5169b2_Cover"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>mgnx-20201125_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:bef8762b-7935-441c-abc4-a2dc43a0414d,g:fd84582f-305c-4baa-8794-528d195fb06f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_ec9a1d1a-e38a-476e-a202-426d40abf548_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_849a7f04-4e60-456a-acb2-43c1542db86c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0252b2dc-245d-493f-a6d1-cc5c1f6e7990_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_be76ea66-fd7a-440a-ae30-054651a9aa89_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_a685dfac-b5c9-43f3-a199-f4ab40d9bf2f_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a6c17fbe-9ee8-4186-bfcf-29baa3fcda07_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7d018e93-0ea3-4353-959d-410353537ea7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_79311618-e5ab-4d22-9274-9223c7d2cd30_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b0c9ed7f-ff64-4a95-9025-5e352d05ceff_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_c8ce733c-ea52-4b5d-9e46-ffbd43901161_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_86d314be-0614-4797-aeef-2d24e9a8de7a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_72baff6e-7be3-4ca0-9f2c-7e83b1254c70_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3804298b-600a-4363-9d61-d4e90a66258e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0ca661f8-1688-44f3-8791-542768290619_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bdc6894f-d05d-45e3-8117-cba202f0a413_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_fbc561fb-9314-4ae5-b605-8fe76b5984bb_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_95925e43-0cb3-448f-a227-73a27632bcac_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_67cb2165-1e88-474c-b957-d39766e582b8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_326a9e37-1398-4479-bf20-ebd42f71ec10_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_836de21a-4bef-48e1-83e3-099c7f24061b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f9bad877-3edc-44ba-ad97-47b564031d10_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8a70fc0f-dfca-4342-863b-d50f8cff2062_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>mgnx-20201125_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:bef8762b-7935-441c-abc4-a2dc43a0414d,g:fd84582f-305c-4baa-8794-528d195fb06f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://macrogenics.com/role/Cover" xlink:type="simple" xlink:href="mgnx-20201125.xsd#Cover"/>
  <link:presentationLink xlink:role="http://macrogenics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_89c468e9-abca-452b-afbe-9a26900869a2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_DocumentType_89c468e9-abca-452b-afbe-9a26900869a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_47076347-f2e7-4aab-8772-f63d9136bc36" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_DocumentPeriodEndDate_47076347-f2e7-4aab-8772-f63d9136bc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e7ed4e8e-2032-4ffd-b988-6e6c4a9e820d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_EntityRegistrantName_e7ed4e8e-2032-4ffd-b988-6e6c4a9e820d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9f59bd46-c9a6-4f73-8950-d1b56a8f715d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9f59bd46-c9a6-4f73-8950-d1b56a8f715d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f436b163-d65c-45e2-b93c-198d2475ceb1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_EntityFileNumber_f436b163-d65c-45e2-b93c-198d2475ceb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6c95fabd-c9c5-49ec-a29a-084fcf0c34e2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_EntityTaxIdentificationNumber_6c95fabd-c9c5-49ec-a29a-084fcf0c34e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_de22d1ab-25fd-4bb3-86ce-14e0675e262b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_EntityAddressAddressLine1_de22d1ab-25fd-4bb3-86ce-14e0675e262b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2395e77b-94d3-4820-9001-6f63fe2d9e08" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_EntityAddressCityOrTown_2395e77b-94d3-4820-9001-6f63fe2d9e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d93c5cd0-a36b-4c49-afef-055732e90513" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_EntityAddressStateOrProvince_d93c5cd0-a36b-4c49-afef-055732e90513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ffb3f424-d712-4d17-8a4b-b9773a00e432" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_EntityAddressPostalZipCode_ffb3f424-d712-4d17-8a4b-b9773a00e432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_76228b21-2971-4148-aea0-ee1dc3a38c31" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_CityAreaCode_76228b21-2971-4148-aea0-ee1dc3a38c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_49e85613-1751-445d-bb52-2e7f9e0e5aac" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_LocalPhoneNumber_49e85613-1751-445d-bb52-2e7f9e0e5aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b2cbeca1-f2b2-4b81-b973-86abe879c0e2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_Security12bTitle_b2cbeca1-f2b2-4b81-b973-86abe879c0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_da2354fb-97d3-41d7-8d65-2458b404a42c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_TradingSymbol_da2354fb-97d3-41d7-8d65-2458b404a42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_37b507b9-dee3-40ba-af68-8820397ba129" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_SecurityExchangeName_37b507b9-dee3-40ba-af68-8820397ba129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_4435c822-63e6-4eb3-b314-504aa9e2d2b8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_WrittenCommunications_4435c822-63e6-4eb3-b314-504aa9e2d2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_3240ff59-c461-4ee2-ac15-6e3a6d94feb2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_SolicitingMaterial_3240ff59-c461-4ee2-ac15-6e3a6d94feb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_43760ed5-6ba9-4f82-afda-79d53dbb96af" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_PreCommencementTenderOffer_43760ed5-6ba9-4f82-afda-79d53dbb96af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_8fd30bae-ce1c-4f42-a72c-e78a67bf83b3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_8fd30bae-ce1c-4f42-a72c-e78a67bf83b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_74f1264c-c9ca-41ca-9f1b-119b9c6f1335" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_EntityEmergingGrowthCompany_74f1264c-c9ca-41ca-9f1b-119b9c6f1335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_adc8f165-6b25-44e4-a978-0623d05c9f8e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_EntityCentralIndexKey_adc8f165-6b25-44e4-a978-0623d05c9f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5af42570-e4ee-4ccf-aa94-c05cbf1f09cd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_681b7a33-d873-4809-9766-aa89a996c3c3" xlink:to="loc_dei_AmendmentFlag_5af42570-e4ee-4ccf-aa94-c05cbf1f09cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
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M]TD4.$0+* 1>G:C89.517WWHF2: VOUEL;A%OYG\XKFQQ*9;X%:>M=9>:NS
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I8$$O:.<Q.DU>Q;RMA]1/D_LRW/\%WO"+6U99-%H     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
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MQ,\S[XA4E;NC(ECMJ-^1]Y\%,7XQ )$:(0!ZFO,@3U@@.?L@C/5!XL-V222
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M202DPFB.G'YH'%@:0 6/:('$@85N]U9B("T*2O/AR'@N*2G;2E6_85UU -V
M1;1^-*W:1H8S@8AB0?H1YH .H# O%KWJ[>UC<^ (0.3"K_8"I(N^=!,]U &T
M1&-1[(?6 Z!]7&E'H6O7&I=(O37_I0-HB78GUYW45G)R!M+2LD"Q(/V(YH .
MH&A^A.YH#ABM 4"J*S>W"-75M:'_Z1=A#N@ "O,BZJJV]O+<_/],9&7E@A8?
MUX^%'- !M) GL-L'F<M^_GP:*/),*\[JQ^(<T $TCR^TG!TM$AKL--VL:US/
MJ]:_[58'4 1K:8IS65DYZ[*@I6OH#/:Z1R33+R,XH ,H@AFT< *YZZ2ZR(#6
M@X81S(EQJ0-HCC$]/7U,;1%X:('UK;+F40Q<+/NQ#B  !![:/9I4%DD@6HE6
MWZ5G>1C:\@"B%<<R,G)#X*'.4HH!Z<?R.+"E 40V#MDZ0<E#J\\& N&Y6<MC
MX=9.M24!1-X6#0JCX1D:>(K8TL74\ZX?-\>!+0<@V@R&UK6F/B[JIB"#^>+%
M*NC@N3G@!%-O*0#1EIMD)--V#-3#3FM;-S0T;\K-\((-N-Z_6P) U(]55W>%
M21Q26[3&=7Y^$2R6\&S4]6Z(S?K^I0&4NY.M<!'8I&.BR15O;^]B(PI)99'!
M3 "BW8=HG+-^K)P#,0%$18OU?X*4\P"$J8Z5OVD-2^ XGL5VJ!^+@!,\:5'T
M@8'EK0B[AN1NZE<M"2":SJ+PT;,B;Z6V9+BNQ28LM!538^-U)FG(UJ&]RTA=
MY>45LFZ)M:#A5OBSF?,L":#5JMCDY!23"+2?!DV)6:W=;FC(*8&&-KJKK*QA
M,T=IB_'"PA)F[]#N011EUJ/*J]62"\M9$P#1:RGV0OO26_IM:&IJ06/3=;2T
MMK-MQNFYSQ=>'F8AF6"#V6GK20)C>WL'VY*<7'#RJ$@UT4DV#NTB1'O4ZYOD
M+L;%U7^V9@"*))W Y!@=8VJEHO(2"@IIF\P<E)56H+2TG/5%T1:;U*U )^V_
M^NFG*4PET5@=4DVTI3B!A]131<4E='5U,S#*\L(5W2/?K5^O+@?6!4#SJT"V
M%NU#-C(R"JO5AJJJ:C8NAU10$$0TM9B>U];6L5T#M1T$I];$MII/KWX?YL"&
M %"8'/UJLW% !]!F:[$-1J\.H W6()N-G/\'[1B%DE"K7&4     245.1*Y"
"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>mgnx-20201125_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mgnx-20201125.xsd" xlink:type="simple"/>
    <context id="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125345</identifier>
        </entity>
        <period>
            <startDate>2020-06-16</startDate>
            <endDate>2020-06-16</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF80L2ZyYWc6MzE1NWM5OTJlNGVlNDcxMzkzZjNiNzRhNTc1OGUyZmYvdGFibGU6M2QxMGFmM2M3OGYxNDVjM2FjOGExMGUxNzU0YWEyYTUvdGFibGVyYW5nZTozZDEwYWYzYzc4ZjE0NWMzYWM4YTEwZTE3NTRhYTJhNV8yLTEtMS0xLTA_a2ada3e1-9c57-458f-8b9f-b892e2ec330d">0001125345</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF80L2ZyYWc6MzE1NWM5OTJlNGVlNDcxMzkzZjNiNzRhNTc1OGUyZmYvdGFibGU6M2QxMGFmM2M3OGYxNDVjM2FjOGExMGUxNzU0YWEyYTUvdGFibGVyYW5nZTozZDEwYWYzYzc4ZjE0NWMzYWM4YTEwZTE3NTRhYTJhNV8zLTEtMS0xLTA_ca6113b8-9952-40ab-b16f-1f457dde932a">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ2_044aaee5-a154-48d9-9cd7-1da13d9681c3">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8yMzI_ffd96351-51ff-4a68-ab34-00fe7185c27e">2020-11-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQy_d4bf748d-291a-436e-b6e8-c2d4fa3fc348">MACROGENICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl8wLTAtMS0xLTA_e171eaa0-02e1-49c0-8992-8922044e0945">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl8wLTMtMS0xLTA_3e536cb7-24eb-45f9-89ac-12f4ff82668c">001-36112</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl8wLTUtMS0xLTA_a442fb1e-2ed7-45e0-99e2-c79d8528566a">06-1591613</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl8zLTAtMS0xLTA_a0d8dfa7-38c3-4248-a5d3-bdada6f431dc">9704 Medical Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl80LTAtMS0xLTA_48f5f846-300c-4b94-ab35-d51e6bdaf751">Rockville,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl80LTEtMS0xLTA_d40ab896-528d-460d-bc1c-7e3bf22a0b94">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6NmVhMThjYzM1ZWNiNDZlOThmZTcwNTQ5NTA1YzQ2ZGIvdGFibGVyYW5nZTo2ZWExOGNjMzVlY2I0NmU5OGZlNzA1NDk1MDVjNDZkYl80LTMtMS0xLTA_e7dcfa55-8a79-4a8e-b7da-fbb95ce16034">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQz_68be31d0-5950-482c-abac-53c65b1981b1">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ3_48ba5f3c-e2d6-49ac-a7f9-9a04b9af6896">251-5172</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6OTBmMTQyZTI3MWM2NGI1M2E4NzgyZWM3NjlkNGIwNTAvdGFibGVyYW5nZTo5MGYxNDJlMjcxYzY0YjUzYTg3ODJlYzc2OWQ0YjA1MF8xLTAtMS0xLTA_05e41695-b926-4427-b34c-be93450eb6c8">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6OTBmMTQyZTI3MWM2NGI1M2E4NzgyZWM3NjlkNGIwNTAvdGFibGVyYW5nZTo5MGYxNDJlMjcxYzY0YjUzYTg3ODJlYzc2OWQ0YjA1MF8xLTEtMS0xLTA_b0e94a0c-dfd6-4084-84f7-ea5b50efbeb3">MGNX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGFibGU6OTBmMTQyZTI3MWM2NGI1M2E4NzgyZWM3NjlkNGIwNTAvdGFibGVyYW5nZTo5MGYxNDJlMjcxYzY0YjUzYTg3ODJlYzc2OWQ0YjA1MF8xLTItMS0xLTA_0399aa45-fc83-4fdc-b8ce-f548180e668f">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ4_85d2aad1-c697-4d02-8f4f-7e83af7bd052">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ0_331c161f-c6d1-4379-8a8e-930f2e0592b2">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ5_e24fbad5-f61f-47b9-ac0e-80f8bbcb5b28">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjQ1_1e069bea-a441-4f1c-b57b-7daa8c1dcd08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616"
      id="id3VybDovL2RvY3MudjEvZG9jOmZiNmQyZWUwOGI1YzQ5ODRiMGJhYTg1YjE5NDFjNjRkL3NlYzpmYjZkMmVlMDhiNWM0OTg0YjBiYWE4NWIxOTQxYzY0ZF8xL2ZyYWc6MzkyYTA0MzU3MmZjNDYzZWI4YTc4M2EyYjRkMjRmZjgvdGV4dHJlZ2lvbjozOTJhMDQzNTcyZmM0NjNlYjhhNzgzYTJiNGQyNGZmOF8xNjUw_5e13164d-5bfd-4b79-9dcc-ae583a5550d6">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140304877672984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 16, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 25,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MACROGENICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">06-1591613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9704 Medical Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rockville,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">251-5172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MGNX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001125345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;%4S.Y68R#/;
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ *81^4660>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( "F$?E&UE+E![@   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( "F$?E&97)PC$ 8
M )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ *81^46BC)- U!   -!   !@              ("!#0@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( "F$?E&#J:4#U $
M #(&   -              "  7@,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  .\2      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mgnx-20201125.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://macrogenics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="mgnx-20201125.htm">mgnx-20201125.htm</File>
    <File>eversanapressrelease.htm</File>
    <File>mgnx-20201125.xsd</File>
    <File>mgnx-20201125_cal.xml</File>
    <File>mgnx-20201125_def.xml</File>
    <File>mgnx-20201125_lab.xml</File>
    <File>mgnx-20201125_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mgnx-20201125.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "mgnx-20201125_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mgnx-20201125_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mgnx-20201125.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mgnx-20201125_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mgnx-20201125_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mgnx-20201125.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mgnx",
   "nsuri": "http://macrogenics.com/20201125",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mgnx-20201125.htm",
      "contextRef": "i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://macrogenics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mgnx-20201125.htm",
      "contextRef": "i97ea587d11ad4d338bf6f195426d057b_D20200616-20200616",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://macrogenics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001125345-20-000155-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001125345-20-000155-xbrl.zip
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ME%C%"W@["A %6>!_+AQ@2(DA =%]3?:WC,\621VFZJCG,5WDD[1BT_7# "Y
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M?F52V+*VH6-W9E:[@]WN[@C_]I_>_"<;[@<@O./_E ;_48_G_P]02P,$%
M  @ *81^49PA#GJ8%P  <)L  !$   !M9VYX+3(P,C Q,3(U+FAT;>U=[5?:
MRM;_?O^*>;C/<Z]=R\&\0D);[_(H>ND1:!7KT2]=D\P$HB'A)$&!O_[9>Y(
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MR:O3IHF_J"%TJV[]U3P\=GNBSZ@?)BD+W>D#_-$R:E1];F!%<RYF#Y%M"Q[
M!;S'IHHZ-UILXM\SW%O4+!\H2F)&<KJXR^_)0:-:1792"UC8_5@2(3TY+H&8
M!>/;'_HB902[I>+OH7_UL;0;A2F EW;& R#0S;Y]+*5BE&Y)>K:V__&/?WQ(
M_300V_UN.*((6U75S ];V8\?MK*NG8B/MS]P_XHDZ3@0'TO<3P8!&]?"*!1
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M,PS0TIX*\1(PFE8Y8Y:K<I<K3P]J75!CPUT-U'G;!VCMQRRNFB]%V3="W(J
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MV4<,>.7^$8Q;0X'2#"&<DRG3F4+C+&7R?K@8C%.IQ?OYT23,\Y@?)YMSFG
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M    ;6=N>"TR,#(P,3$R-5]D968N>&ULK93);MLP$(;O?@I6O9:F*%&;83M
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MN&/_U>V![J-[+7__U?\ 4$L! A0#%     @ *81^4;/\;PJ$$0  +T0  !@
M             ( !     &5V97)S86YA<')E<W-R96QE87-E+FAT;5!+ 0(4
M Q0    ( "F$?E&<(0YZF!<  '";   1              "  ;H1  !M9VYX
M+3(P,C Q,3(U+FAT;5!+ 0(4 Q0    ( "F$?E&J9DW]BP(  '0)   1
M          "  8$I  !M9VYX+3(P,C Q,3(U+GAS9%!+ 0(4 Q0    ( "F$
M?E&Z] XWA0$  ,0"   5              "  3LL  !M9VYX+3(P,C Q,3(U
M7V-A;"YX;6Q02P$"% ,4    "  IA'Y1[ALK? <"  !I!@  %0
M    @ 'S+0  ;6=N>"TR,#(P,3$R-5]D968N>&UL4$L! A0#%     @ *81^
M4>&BD<I="@  HET  !4              ( !+3   &UG;G@M,C R,#$Q,C5?
M;&%B+GAM;%!+ 0(4 Q0    ( "F$?E&!K?6.L 8  &0Q   5
M  "  ;TZ  !M9VYX+3(P,C Q,3(U7W!R92YX;6Q02P4&      < !P#0 0
&H$$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
